Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

CCL Biomedical

CCL Biomedical
Out of Business LATEST DEAL TYPE

Developer of antimicrobial compounds intended to be used for combatting serious health issues and reducing the number of infections and deaths. The company's antimicrobial compounds helps in effective destruction of micro-organisms and biofilm control, enabling clients to avail effective products to address their individual needs.

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Other Healthcare Services
Primary Office
  • Havre de Grace, MD 21078
  • United States

+1 (240) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore CCL Biomedical’s full profile, request a free trial.

CCL Biomedical Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 01-Apr-2018 Completed Out of Business
5. Later Stage VC Completed Generating Revenue
4. Grant 01-Jan-2013 00000 Completed Generating Revenue
3. Grant 01-Jan-2009 00000 Completed Generating Revenue
2. Grant 01-Jan-2007 $600K Completed Generating Revenue
1. Grant 01-Jan-2003 $270K Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

CCL Biomedical Executive Team (2)

Name Title Board
Stuart Cooper Co-Founder

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »